Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of RF16001 local infiltration analgesia after total hip arthroplasty
CTR20262594Phase 3Active
- Sponsor
- Yichang Humanwell Pharmaceutical Co., Ltd.
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of RF16001 in postoperative pain, sponsored by Yichang Humanwell Pharmaceutical Co., Ltd.. Started Sep 2026; status: active.
02
Drugs
RF16001
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20262594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262594.